{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"lymphedema-cerebral-arteriovenous-anomaly","columns":[{"gene":"","key":"population-0103584c41b461a2b8d0","label":"Lymphedema and cerebral arteriovenous anomaly","mondoId":"MONDO:0007917","onsetQualifier":null,"originColumnKey":"MONDO:0007917/OMIM:152900","originalViews":[{"key":"MONDO:0007917/OMIM:152900","label":"Lymphedema and cerebral arteriovenous anomaly","scopeLabel":"OMIM:152900","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["3c40497fd9b1d604e0299d506e4b17b113e0ae6e1a64f8a29e1e067082004e5a","3d2677fb61f3831d75db37a1394a8dfd09b068c96676f17f8e044e4d7d63dd7c","472ee254f1425bd5e7d387b86f200f809df112e1156d200aafefa4d5d08b3346"],"recordQualifiers":{},"scopeLabel":"OMIM:152900","sourceIds":["OMIM:152900"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-0103584c41b461a2b8d0"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0100659","HP:0001004","HP:0002092"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":3,"sourceGroups":{"omim":3}},"features":[{"hpoId":"HP:0100659","label":"Abnormal cerebral vascular morphology","primary":true},{"hpoId":"HP:0001004","label":"Lymphedema","primary":true},{"hpoId":"HP:0002092","label":"Pulmonary arterial hypertension","primary":true}],"ledeHtml":"Lymphedema-cerebral arteriovenous anomaly syndrome is characterised by the variable association of a cerebrovascular malformation, foot lymphoedema and primary pulmonary hypertension. It has been described in a woman and four of her children. There have been no further descriptions in the literature since 1986.","mondoId":"MONDO:0007917","node":{"canonicalSlug":"lymphedema-cerebral-arteriovenous-anomaly","comparisons":[{"documentSha256":"d3f3297eae13bfece693ea16e00fcd25dfe9824e17f996c124fc06fbf7934494","key":"legacy-lymphedema-cerebral-arteriovenous-anomaly","kind":"legacy","label":"lymphedema-cerebral arteriovenous anomaly syndrome","memberIds":["MONDO:0007917"],"mondoId":"MONDO:0007917","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/lymphedema-cerebral-arteriovenous-anomaly.d3f3297eae13bfece693ea16e00fcd25dfe9824e17f996c124fc06fbf7934494.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Lymphedema-cerebral arteriovenous anomaly syndrome","originalSourceId":"ORPHA:86914","paragraphs":["Lymphedema-cerebral arteriovenous anomaly syndrome is characterised by the variable association of a cerebrovascular malformation, foot lymphoedema and primary pulmonary hypertension. It has been described in a woman and four of her children. There have been no further descriptions in the literature since 1986."],"rawAttribution":"MONDO:0007917","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:06:28Z","upstream":"MONDO:0007917","url":"https://rarediseases.info.nih.gov/diseases/9217"},"ownColumnKeys":["population-0103584c41b461a2b8d0"],"publication":"published","relationships":[{"kind":"parent","label":"syndromic disease","mondoId":"MONDO:0002254","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"3c40497fd9b1d604e0299d506e4b17b113e0ae6e1a64f8a29e1e067082004e5a","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:152900","disease_name":"Lymphedema and cerebral arteriovenous anomaly","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002092","is_excluded":false,"label":"Pulmonary arterial hypertension","onset_id":null,"reference":"OMIM:152900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"3d2677fb61f3831d75db37a1394a8dfd09b068c96676f17f8e044e4d7d63dd7c","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:152900","disease_name":"Lymphedema and cerebral arteriovenous anomaly","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0100659","is_excluded":false,"label":"Abnormal cerebral vascular morphology","onset_id":null,"reference":"OMIM:152900","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"472ee254f1425bd5e7d387b86f200f809df112e1156d200aafefa4d5d08b3346","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:152900","disease_name":"Lymphedema and cerebral arteriovenous anomaly","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001004","is_excluded":false,"label":"Lymphedema","onset_id":null,"reference":"OMIM:152900","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9217\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007917\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0007917</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Lymphedema-cerebral arteriovenous anomaly syndrome is characterised by the variable association of a cerebrovascular malformation, foot lymphoedema and primary pulmonary hypertension. It has been described in a woman and four of her children. There have been no further descriptions in the literature since 1986.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9217\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"lymphedema-cerebral-arteriovenous-anomaly","sourceDocuments":[{"name":"GARD: Lymphedema-cerebral arteriovenous anomaly syndrome","reviewed":null,"source_release":"2026-10-21T17:06:28Z","url":"https://rarediseases.info.nih.gov/diseases/9217"},{"name":"MONDO: lymphedema-cerebral arteriovenous anomaly syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007917"}],"sourceNote":"","synonyms":["primary pulmonary hypertension, cerebrovascular malformation and lymphedema feet"],"takeawayHtml":"","title":"lymphedema-cerebral arteriovenous anomaly syndrome"},"schemaVersion":1}
